Causal link between neonatal hydronephrosis and later development of hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages

  Carlström, Mattias ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Nitric oxide; Obstructive nephropathy; Oxidative stress; Renal denervation; Renal sympathetic nerve activity; Renin angiotensin system; Tubuloglomerular feedback; Ureteral obstruction

Indexed keywords

ADENOSINE; ALPHA TOCOPHEROL; ANGIOTENSIN II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RENIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

HUMAN; HYDRONEPHROSIS; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; NEWBORN DISEASE; NONHUMAN; OBSTRUCTIVE NEPROPATHY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URETER OBSTRUCTION;

ADULT; ANIMALS; CHILD; HUMANS; HYDRONEPHROSIS; HYPERTENSION; INFANT; INFANT, NEWBORN; KIDNEY; MALE; MICE; NEPHRITIS; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TIME; URETERAL OBSTRUCTION;

EID: 75649106814     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05267.x     Document Type: Review

References (84)

1. Livera LN, Brookfield DS, Egginton JA, Hawnaur JM. Antenatal ultrasonography to detect fetal renal abnormalities: A prospective screening programme. BMJ 1989 298 : 1421 1423.
2. Thomas DF. Fetal uropathy. Br. J. Urol. 1990 66 : 225 231.
3. Podevin G, Mandelbrot L, Vuillard E, Oury JF, Aigrain Y. Outcome of urological abnormalities prenatally diagnosed by ultrasound. Fetal Diagn. Ther. 1996 11 : 181 190.
4. Dhillon HK. Prenatally diagnosed hydronephrosis: The Great Ormond Street experience. Br. J. Urol. 1998 81 (Suppl. 2 39 44.
5. Koff SA, Campbell KD. The nonoperative management of unilateral neonatal hydronephrosis: Natural history of poorly functioning kidneys. J. Urol. 1994 152 : 593 595.
6. Ulman I, Jayanthi VR, Koff SA. The long-term followup of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J. Urol. 2000 164 : 1101 1105.
7. Barratt TM, Avner ED, Harmon WE. Pediatric Nephrology, 4th edn. Lippincott, Williams & Wilkins, Philadelphia. 1999.
8. de Waard D, Dik P, Lilien MR, Kok ET, de Jong TP. Hypertension is an indication for surgery in children with ureteropelvic junction obstruction. J. Urol. 2008 179 : 1976 1978.
9. Abramson M, Jackson B. Hypertension and unilateral hydronephrosis. J. Urol. 1984 132 : 746 748.
10. Wanner C, Luscher TF, Schollmeyer P, Vetter W. Unilateral hydronephrosis and hypertension: Cause or coincidence? Nephron 1987 45 : 236 241.
11. Ameur A, Zarzur J, Jira H, Touiti D, el Alami M, Abbar M. [Hydronephrosis arterial hypertension. Report of 4 cases. Ann. Urol. 2002 36 : 157 161 (in French).
12. Kawano S, Yano S, Takahashi S, Nomura Y, Ogata J. A case of hypertension due to unilateral hydronephrosis in a child. Eur. Urol. 1986 12 : 357 359.
13. Palmer JM, Zweiman FG, Assaykeen TA. Renal hypertension due to hydronephrosis with normal plasma renin activity. N. Engl. J. Med. 1970 283 : 1032 1033.
14. Riehle Jr. RA, Vaughan Jr. ED. Renin participation in hypertension associated with unilateral hydronephrosis. J. Urol. 1981 126 : 243 246.
15. Ulm AH, Miller F. An operation to produce experimental reversible hydronephrosis in dogs. J. Urol. 1962 88 : 337 341.
16. Wen JG, Frokiaer J, Jorgensen TM, Djurhuus JC. Obstructive nephropathy: An update of the experimental research. Urol. Res. 1999 27 : 29 39.
17. Peters CA. Animal models of fetal renal disease. Prenat. Diagn. 2001 21 : 917 923.
18. Chevalier RL. Chronic partial ureteral obstruction and the developing kidney. Pediatr. Radiol. 2008 38 (Suppl. 1 S35 40.
19. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002 283 : F861 75.
20. Kawada N, Moriyama T, Ando A et al. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 1999 56 : 1004 1013.
21. Sugiyama H, Kobayashi M, Wang DH et al. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol. Dial. Transplant. 2005 20 : 2670 2680.
22. Moriyama T, Kawada N, Nagatoya K et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int. 2001 59 : 2095 2103.
23. Lin KC, Krieg Jr. RJ, Saborio P, Chan JC. Increased heat shock protein-70 in unilateral ureteral obstruction in rats. Mol. Genet. Metab. 1998 65 : 303 310.
24. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G. Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants. Kidney Int. 2005 67 : 931 943.
25. Manucha W, Carrizo L, Ruete C, Molina H, Valles P. Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy. Cell. Mol. Biol. 2005 51 : 547 555.
26. Singh D, Kaur R, Chander V, Chopra K. Antioxidants in the prevention of renal disease. J. Med. Food 2006 9 : 443 450.
27. Wen JG. Partial unilateral ureteral obstruction in rats. Neurourol. Urodyn. 2002 21 : 231 250.
28. Carlstrom M, Sallstrom J, Skott O, Larsson E, Wahlin N, Persson AE. Hydronephrosis causes salt-sensitive hypertension and impaired renal concentrating ability in mice. Acta Physiol. 2007 189 : 293 301.
29. Li C, Wang W, Kwon TH et al. Downregulation of AQP1-2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect. Am. J. Physiol. Renal Physiol. 2001 281 : F163 71.
30. Shi Y, Li C, Thomsen K et al. Neonatal ureteral obstruction alters expression of renal sodium transporters and aquaporin water channels. Kidney Int. 2004 66 : 203 215.
31. Cochrane AL, Kett MM, Samuel CS et al. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J. Am. Soc. Nephrol. 2005 16 : 3623 3630.
32. Carlstrom M, Wahlin N, Skott O, Persson AE. Relief of chronic partial ureteral obstruction attenuates salt-sensitive hypertension in rats. Acta Physiol. 2007 189 : 67 75.
33. Schnermann J, Persson AE, Agerup B. Tubuloglomerular feedback. Nonlinear relation between glomerular hydrostatic pressure and loop of Henle perfusion rate. J. ClInvest. 1973 52 : 862 869.
34. Morsing P, Stenberg A, Muller-Suur C, Persson AE. Tubuloglomerular feedback in animals with unilateral, partial ureteral occlusion. Kidney Int. 1987 32 : 212 218.
35. Persson AE, Bianchi G, Boberg U. Tubuloglomerular feedback in hypertensive rats of the Milan straActa Physiol. Scand. 1985 123 : 139 146.
36. Dilley JR, Arendshorst WJ. Enhanced tubuloglomerular feedback activity in rats developing spontaneous hypertension. Am. J. Physiol. 1984 247 : F672 9.
37. Liu R, Ren Y, Garvin JL, Carretero OA. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int. 2004 66 : 268 274.
38. Ollerstam A, Pittner J, Persson AE, Thorup C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J. ClInvest. 1997 99 : 2212 2218.
39. Wilcox CS, Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol. Scand. 2000 168 : 119 124.
40. Josephson S, Lannergren K, Eklof AC. Partial ureteric obstruction in weanling rats. II. Long-term effects on renal function and arterial blood pressure. Urol. Int. 1992 48 : 384 390.
41. Stenberg A, Olsen L, Engstrand U, Persson AE. Pressure and flow measurements in the partially obstructed ureter of the rat. Scand. J. Urol. Nephrol. 1988 22 : 279 288.
42. Tauchi K, Kanehara H. Hypertension and the renin-angiotensin system in the congenital hydronephrosis rat with non-obstructive pelviureteric junction abnormalities. Exp. Nephrol. 1996 4 : 60 4.
43. Pettersson BA, Aperia A, Elinder G. Pathophysiological changes in rat kidneys with partial ureteral obstruction since infancy. Kidney Int. 1984 26 : 122 127.
44. Carlstrom M, Wahlin N, Sallstrom J, Skott O, Brown R, Persson AE. Hydronephrosis causes salt-sensitive hypertension in rats. J. Hypertens. 2006 24 : 1437 1443.
45. Pak K, Kawamura J, Yoshida O. Hypertension with elevated renal vein renin secondary to unilateral hydronephrosis. Urology 1980 16 : 499 501.
46. Weidmann P, Beretta-Piccoli C, Hirsch D, Reubi FC, Massry SG. Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renAnn. Intern. Med. 1977 87 : 437 440.
47. Chevalier RL. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr. Nephrol. 1999 13 : 612 619.
48. Topcu SO, Pedersen M, Norregaard R. et al. Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 2007 292 : F736 48.
49. Watanabe M, Nishikawa T, Takagi T, Kamiyama Y, Tamura Y, Kumagai A. Mechanism of suppressed renin-angiotensin system in spontaneously hypertensive rat (SHR). ClExp. Hypertens. A 1983 5 : 49 70.
50. Schiffrin EL, Thome FS, Genest J. Vascular angiotensin II receptors in SHR. Hypertension 1984 6 : 682 688.
51. Majid DS, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. ClExp. Pharmacol. Physiol. 2007 34 : 946 952.
52. DiBona GF, Kopp UC. Neural control of renal function. Physiol. Rev. 1997 77 : 75 197.
53. Kopp UC, Buckley-Bleiler RL. Impaired renorenal reflexes in two-kidney, one-clip hypertensive rats. Hypertension 1989 14 : 445 452.
54. Kopp UC, Smith LA, DiBona GF. Impaired renorenal reflexes in spontaneously hypertensive rats. Hypertension 1987 9 : 69 75.
55. Norman Jr. RA, Murphy WR, Dzielak DJ, Khraibi AA, Carroll RG. Role of the renal nerves in one-kidney, one-clip hypertension in rats. Hypertension 1984 6 : 622 626.
56. Thorup C, Kurkus J, Morsing P, Persson AE. Acute renal denervation causes time-dependent resetting of the tubuloglomerular feedback mechanism. Acta Physiol. Scand. 1995 153 : 43 9.
57. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005 289 : R913 35.
58. Lim DS, Mooradian SJ, Goldberg CS et al. Effect of oral l-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients. Am. J. Cardiol. 2004 94 : 828 831.
59. Palloshi A, Fragasso G, Piatti P et al. Effect of oral l-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am. J. Cardiol. 2004 93 : 933 935.
60. Schramm L, La M, Heidbreder E et al. l-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int. 2002 61 : 1423 1432.
61. Dumont Y, D'Amours M, Lebel M, Lariviere R. Supplementation with a low dose of l-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Nephrol. Dial. Transplant. 2001 16 : 746 754.
62. Gouvea SA, Moyses MR, Bissoli NS, Pires JG, Cabral AM, Abreu GR. Oral administration of l-arginine decreases blood pressure and increases renal excretion of sodium and water in renovascular hypertensive rats. Braz. J. Med. Biol. Res. 2003 36 : 943 949.
63. Katoh T, Takahashi K, Klahr S, Reyes AA, Badr KF. Dietary supplementation with l-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J. Am. Soc. Nephrol. 1994 4 : 1690 1694.
64. Laurant P, Demolombe B, Berthelot A. Dietary l-arginine attenuates blood pressure in mineralocorticoid-salt hypertensive rats. ClExp. Hypertens. 1995 17 : 1009 1024.
65. Moura JR, Sass N, Guimaraes SB et al. Effects of l-arginine oral supplements in pregnant spontaneously hypertensive rats. Acta Cir. Bras. 2006 21 : 291 295. (Pubitemid 44544086)
66. Reyes AA, Purkerson ML, Karl I, Klahr S. Dietary supplementation with l-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am. J. Kidney Dis. 1992 20 : 168 176.
67. Carlstrom M, Brown RD, Edlund J et al. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals. Am. J. Physiol. Renal Physiol. 2008 294 : F362 70.
68. Kinter M, Wolstenholme JT, Thornhill BA, Newton EA, McCormick ML, Chevalier RL. Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion. Kidney Int. 1999 55 : 1327 1334.
69. Carlstrom M, Brown RD, Sallstrom J et al. SOD1-deficiency causes salt-sensitivity and aggravates hypertension in hydronephrosis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 297 : 82 92.
70. Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 2005 24 : 201 208.
71. Siems W, Quast S, Carluccio F et al. Oxidative stress in chronic renal failure as a cardiovascular risk factor. ClNephrol. 2002 58 (Suppl. 1 S12 19.
72. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol. Rev. 2008 60 : 418 469.
73. Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am. J. Physiol. Renal Physiol. 2007 292 : F1404 10.
74. Patzak A, Persson AE. Angiotensin II-nitric oxide interaction in the kidney. Curr. OpNephrol. Hypertens. 2007 16 : 46 51.
75. Just A. Mechanisms of renal blood flow autoregulation: Dynamics and contributions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 292 : R1 17.
76. Seeliger E, Wronski T, Ladwig M et al. The renin-angiotensin system and the third mechanism of renal blood flow autoregulation. Am. J. Physiol. Renal Physiol. 2009 296 : F1334 45.
77. Carlstrom M, Lai EY, Ma Z, Patzak A, Brown RD, Persson AE. Role of NOX2 in the regulation of afferent arteriole responsiveness. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 296 : R72 9.
78. Patzak A, Lai EY, Fahling M et al. Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 293 : R2232 42.
79. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol. Scand. 2003 179 : 217 223.
80. Carlstrom M, Lai EY, Steege A et al. Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension. Hypertension 2008 51 : 1386 1392. (Pubitemid 351555954)
81. Chen YF, Li PL, Zou AP. Oxidative stress enhances the production and actions of adenosine in the kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001 281 : R1808 16.
82. Carlstrom M, Persson AE. Important role of NAD(P)H oxidase 2 in the regulation of the tubuloglomerular feedback. Hypertension 2009 53 : 456 457.
83. Chevalier RL. Obstructive nephropathy: Towards biomarker discovery and gene therapy. Nat. ClPract. Nephrol. 2006 2 : 157 168.
84. Decramer S, Zürbig P, Wittke S, Mischak H, Bascands JL, Schanstra JP. Identification of urinary biomarkers by proteomics in newborns: Use in obstructive nephropathy. Contrib. Nephrol. 2008 160 : 127 141.